Physician Liability for Genetic Risk-Based Prescription Decisions

Area of Science:

• Medical Genetics
• Pharmacogenomics
• Legal Medicine

Background:

• Genetic testing for opioid use disorder (OUD) risk is emerging.
• Concerns exist regarding test accuracy (false positives/negatives) and clinical utility.
• Physicians may over-rely on genetic data, neglecting multifactorial OUD risk.

Purpose of the Study:

• To examine physician liability risks associated with using genetic tests for OUD risk assessment.
• To analyze potential legal recourse for patients harmed by genetic test-guided clinical decisions.
• To evaluate the adequacy of current tort law in addressing these issues.

Main Methods:

• Review of legal frameworks and potential physician liability scenarios.
• Analysis of clinical decision-making in the context of genetic risk prediction.
• Discussion of ethical and practical implications of genetic testing for OUD.

Main Results:

• Physicians face liability for inappropriate prescribing, denial of care, or failure to test based on genetic results.
• Genetic test results can lead to undertreatment of pain or inappropriate opioid prescriptions.
• Existing tort law provides insufficient protection for patients and guidance for clinicians.

Conclusions:

• The integration of genetic tests for OUD risk into clinical practice poses significant liability challenges for physicians.
• Current legal and ethical frameworks are inadequate to manage the risks and ensure patient safety.
• Relying solely on tort law will not mitigate the harms associated with these predictive genetic tests.